The global Protein A resins market is on a strong upward trajectory, with expectations to reach USD 677.84 million in 2023 and grow to USD 1,477.01 million by 2033. According to the latest study by Future Market Insights (FMI), this significant growth is driven by the increasing demand for advanced protein purification technologies across various industries, including pharmaceuticals, biotechnology, and life sciences.
The market is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 8.1% from 2023 to 2033, highlighting the growing adoption of Protein A resins in therapeutic protein production and other applications. Protein A resins, integral to the purification of monoclonal antibodies (mAbs) and other biologics, are seeing rising demand due to their high efficiency and ability to streamline production processes.
FMI’s analysis reveals a clear division in product demand, with the natural protein A resin segment projected to dominate the market throughout the forecast period. Natural protein A resins are expected to account for the largest share of sales due to their superior binding capacity, making them ideal for large-scale production of therapeutic proteins and antibodies.
With the expanding scope of applications, particularly in the biopharmaceutical industry, the Protein A resins market is poised for significant growth in the coming years. This growth is further fueled by advancements in biotechnology, an increased focus on biologics, and the ongoing evolution of protein purification technologies.
As industries seek to meet the growing demand for high-quality therapeutic proteins and biologics, Protein A resins will play a critical role in ensuring the efficiency and scalability of production processes worldwide.
Top Highlights from the FMI’s Analysis of the Protein A Resins Market:
- The United States protein A resins industry is expected to acquire more than 93.5% value share of the North America market.
- Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
- The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
- High demand for natural protein A resin is expected to yield a large market share in 2023.
- Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
- The antibody purification segment is projected to gain 74.8% of the global market.
- The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!
Leading Players Back New Initiatives to Boost Protein A Resin Trading:
Key companies in the protein A resins market are strengthening their positions through strategic approvals, collaborations, mergers and acquisitions, and partnerships with both established and emerging market players. These initiatives, including product launches and acquisitions, are designed to help manufacturers capture a larger market share. Notable examples include:
- In June 2021, Bio-Rad Laboratories, Inc. partnered with Seegene, Inc., a leader in multiplex molecular diagnostics. This collaboration aims to drive the commercialization and clinical development of molecular diagnostic products for infectious diseases.
- In September 2021, Thermo Fisher Scientific Inc. announced the opening of a new manufacturing plant in Nashville. This facility will produce single-use technology products, ensuring a reliable supply of critical materials for the development of new biologics and vaccines.
Key Players in the Market are:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
Protein A Resins Market by Category:
Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
Matrix:
- Agarose-based Matrix
- Glass or Silica-based Matrix
- Organic Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody Purification
End User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
The Middle East and Africa (MEA)
